DE102014225083A1 - Hair treatment agent with anti-dandruff action - Google Patents

Abstract

The invention relates to a hair treatment composition which - based on its weight - a) 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, and b) 0.10 to 25.00 wt .-% of at least one C2- Contains C4-diols. The invention further relates to the cosmetic use of at least one C2-C4-diol for increasing the anti-dandruff efficacy of hair treatment compositions containing at least one inorganic zinc salt as antidandruff active ingredient, as well as a cosmetic method for the elimination, reduction, alleviation and / or prevention of dandruff.

Description

The invention is in the field of cosmetics and relates to hair treatment compositions containing at least one inorganic zinc salt and at least one C ₂ -C ₄ diol. The invention further relates to the cosmetic use of C ₂ -C ₄ -diols for increasing the anti-dandruff efficacy of hair treatment compositions containing at least one inorganic zinc salt as anti-dandruff active, and a cosmetic method for eliminating, reducing, alleviating and / or preventing dandruff.

An important aspect of cosmetic hair treatment is the fight against dandruff, because even the slight appearance of dandruff on the scalp or other hairy parts of the body is considered a sign of lack of care and hygiene. In addition, dandruff is usually associated with a tormenting itching, which can cause scratching reactions on the skin, so that injury to the affected skin can occur. In turn, skin injuries often form the basis for infections and pathogenic agents. Dandruff may be caused by a variety of factors such as hereditary predisposition, seborrhea, hormonal imbalances, stress, climatic conditions or improper hair care. The decisive contribution to dandruff, however, provides the colonization of the scalp with yeast fungi of the genus Malassezia. In the fight against dandruff one has therefore always endeavored to reduce the germination of the scalp with Malassezia and / or eliminate. A variety of cosmetically acceptable and effective anti-dandruff agents are commonly known in the art which are commonly incorporated into scalp shampoos or tonics. Common anti-dandruff agents include, for example, Piroctone olamine, climbazole, zinc pyrithione, special plant extracts, sulfur and / or selenium sulfide. In GB 2205743A Propylene glycol is proposed in an amount of> 30 wt .-% as an effective antidandruff active. Out EP 348015A1 the use of zinc salts as anti-dandruff agents is known. Combination of several conventional antidandruff agents (climbazole, zinc pyrithione and piroctone olamine) has also been proposed ( EP 1238645A1 ).

However, anti-dandruff agents known from the prior art often have the disadvantage that the desired effect occurs only after frequent and / or regular use. In addition, with increasing efficacy against dandruff the skin compatibility of anti-dandruff preparations often decreases, so that the dandruff stressed by dandruff can be additionally burdened. Rough, chapped skin and / or intense itching can be the result.

The present application was based on the object to provide well-tolerated hair treatment agents with which dandruff can be quickly, effectively and permanently eliminated, reduced, alleviated and / or prevented. The properties of the hair should not be negatively affected.

It has now surprisingly been found that the abovementioned objects are achieved to an outstanding extent by hair treatment compositions containing at least one inorganic zinc salt and at least one C ₂ -C ₄ -diol. The addition of at least one C ₂ -C ₄ diol to hair treatment agents containing inorganic zinc salts results in a significant increase in antidandruff efficacy of the agents. In addition, the hair treatment agents are very good (head) skin-friendly and show an excellent anti-dandruff efficacy even after a single application. Treated hair has optically and haptically appealing properties (gloss, suppleness, soft touch) and the scalp-related itching of the scalp can be effectively reduced or eliminated by using the hair treatment agent.

• a) 0,01 bis 2,50 Gew.-% mindestens eines anorganischen Zinksalzes und
• b) 0,10 bis 25,00 Gew.-% mindestens eines C₂-C₄-Diols enthält.

A first subject of the invention is therefore a hair treatment composition which - based on its weight -

• a) 0.01 to 2.50 wt .-% of at least one inorganic zinc salt and
• b) 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol.

The hair treatment compositions according to the invention contain the active ingredients a) and b) preferably in a cosmetically acceptable carrier. For the purposes of the invention, this is preferably understood as meaning an aqueous or aqueous-alcoholic carrier. The cosmetic carrier preferably contains at least 50% by weight, more preferably at least 60% by weight, more preferably at least 65% by weight and most preferably at least 70% by weight of water. Furthermore, the cosmetic carrier may contain from 0.01 to 30% by weight, preferably from 0.05 to 20% by weight and in particular from 0.1 to 10% by weight, of at least one alcohol other than b). Suitable alcohols are, for example, ethanol, 1-propanol, 2-propanol, isopropanol, glycerol, diglycerol, triglycerol, 1-butanol, 2-butanol, 1-pentanol, 2-pentanol, 1,2-pentanediol, 1,5-pentanediol, 1, hexanol, 2- Hexanol, 1,2-hexanediol, 1,6-hexanediol, polyethylene glycols, sorbitol, sorbitan, benzyl alcohol, phenoxyethanol or mixtures of these alcohols. Particularly preferred are the water-soluble alcohols. Particularly preferred are ethanol, glycerol, benzyl alcohol and / or phenoxyethanol and mixtures of these alcohols.

It has been found that the anti-dandruff efficacy of hair treatment agents according to the invention is particularly high when water-insoluble inorganic zinc salts are used. Water-insoluble inorganic zinc salts can be further optimized by controlling their physical parameters such as particle size, specific surface area, bulk density, surface charge, refractive index, degree of purity etc. in their properties, in particular with regard to their antidandruff activity. By "water-insoluble" is meant that at 20 ° C less than 1 g of the respective inorganic zinc salt a) are soluble in 1 liter of water. Preferably, less than 100 mg, more preferably less than 50 mg and in particular less than 25 mg of the respective salt a) at 20 ° C in 1 liter of water are soluble.

In a first embodiment therefore hair treatment compositions according to the invention are preferred which contain at least one water-insoluble inorganic zinc salt a).

Preferred inorganic zinc salts a) which can be used in the hair treatment compositions according to the invention are zinc aluminate, zinc carbonate, zinc oxide, calamines, zinc phosphates (orthophosphates and / or pyrophosphates), zinc selenide, zinc sulfide, zinc silicates (ortho- and / or meta-zinc silicates), zinc borates , Zinc hydroxides and / or zinc hydroxysulfates. Particularly preferred are zinc oxide and / or zinc carbonate; particular preference is given to zinc oxide.

The proportion by weight of the at least one inorganic zinc salt a) in the total weight of the hair treatment compositions according to the invention is from 0.01 to 2.50% by weight. Preference is given to a proportion by weight of from 0.02 to 2.00% by weight, more preferably from 0.03 to 1.75% by weight, particularly preferably from 0.04 to 1.50% by weight, very particularly preferably from 0.05 to 1.25 and in particular from 0.075 to 1.00 wt .-%.

In a second preferred embodiment, hair treatment agents according to the invention contain as inorganic zinc salt a) zinc oxide and / or zinc carbonate.

In a third preferred embodiment, hair treatment compositions according to the invention contain, based on their weight, 0.02 to 2.00% by weight, more preferably 0.03 to 1.75% by weight, particularly preferably 0.04 to 1, 50 wt .-%, most preferably from 0.05 to 1.25 and in particular from 0.075 to 1.00 wt .-% zinc oxide.

A second essential component in the hair treatment compositions according to the invention is at least one C ₂ -C ₄ diol b). It has been found that short-chain diols can significantly increase and maintain the antidandruff activity of the inorganic zinc salts a) in the hair treatment compositions according to the invention.

Suitable C ₂ -C ₄ diols may be selected from 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol and / or 1,4-butylene glycol. Particularly preferred are the propylene glycols. Particularly preferred is 1,3-propylene glycol.

The proportion by weight of the at least one C ₂ -C ₄ diol b) in the total weight of the hair treatment compositions according to the invention is from 0.10 to 25.00% by weight. Preference is given to a weight fraction of 0.20 to 20.00 wt .-%, more preferably from 0.30 to 17.50 wt .-%, particularly preferably from 0.40 to 15.00 wt .-%, most preferably from 0.50 to 12.50 and in particular from 0.75 to 10.00 wt .-%.

In a fourth preferred embodiment, hair treatment compositions according to the invention contain, by weight, from 0.20 to 20.00% by weight, more preferably from 0.30 to 17.50% by weight, particularly preferably from 0.40 to 15, 00 wt .-%, more preferably from 0.50 to 12.50 and in particular from 0.75 to 10.00 wt .-% 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1 , 3-Butylene glycol and / or 1,4-butylene glycol

Within this embodiment, it is particularly preferred if the hair treatment agents contain 1,2-propylene glycol and / or 1,3-propylene glycol, preferably 1,3-propylene glycol.

The hair treatment compositions according to the invention may in principle be in the form of any hair treatment agent, for example as hair cleanser, hair conditioner, hair conditioner, Hair styling agent, hair Tonic, etc., are present. However, preferred hair treatment compositions according to the invention, which are formulated as a hair shampoo and / or hair tonic.

In a further preferred embodiment, the hair treatment composition according to the invention is therefore a hair shampoo or a hair tonic.

In the event that hair treatment compositions according to the invention are formulated as hair shampoo is to ensure that the cleaning of the hair does not pollute the scalp.

Hair shampoos which have a pH in the slightly acidic range and / or which contain a limited amount of surfactant and / or which comprise a mixture of particularly (mild) surfactant types have therefore proven to be particularly preferred. Particularly preferred are hair shampoos which have a pH in the range from 4.0 to 6.5, preferably from 4.2 to 6.2, particularly preferably from 4.3 to 6.0 and in particular from 4.5 to 5, 7 have. A total surfactant content of at most 25% by weight, based on the weight of the hair treatment agent according to the invention, is preferred. More preferably, a total surfactant content of at most 20.00% by weight, more preferably of at most 17.50% by weight, and most preferably of at most 15.00% by weight, is preferred. A mixture of at least one anionic surfactant c) and at least one amphoteric / zwitterionic surfactant d) has proven to be a particularly mild surfactant mixture for the hair treatment compositions according to the invention.

In a fifth preferred embodiment, the hair treatment compositions according to the invention therefore contain, based on their weight, 0.01 to 25.00% by weight of at least one anionic surfactant c) and at least one amphoteric / zwitterionic surfactant d).

• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Ethercarbonsäuren der Formel R-O-(CH₂-CH₂O)_x-CH₂-COOH, in der R eine lineare oder verzweigte, gesättigte oder ungesättigte Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist,
• – Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Sulfobernsteinsäuremono- und/oder -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen,
• – Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Alkylsulfate und/oder Alkylethersulfatsalze der Formel R-(OCH₂-CH₂)_n-O-SO₃X, in der R bevorzugt eine geradkettige oder verzweigte, gesättigte oder ungesättigte Alkylgruppe mit 8 bis 30 C-Atomen, x die Zahl 0 oder 1 bis 12 und X ein Alkali-, Erdalkali-, Ammonium- oder Alkanolaminion bedeutet,
• – Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen,
• – Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2–15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen, und/oder
• – Alkyl- und/oder Alkenyletherphosphate der Formel
  
  in der R¹ bevorzugt für einen aliphatischen Kohlenwasserstoffrest mit 8 bis 30 Kohlenstoffatomen, R² für Wasserstoff, einen Rest (CH₂CH₂O)_nR¹ oder X, n für Zahlen von 0 bis 10 und X für Wasserstoff, ein Alkali- oder Erdalkalimetall oder die Gruppe -NR³R⁴R⁵R⁶ steht, mit R³ bis R⁶ unabhängig voneinander stehend für einen C₁ bis C₄-Kohlenwasserstoffrest.

Suitable anionic surfactant types c) which can be used in the hair treatment compositions according to the invention include, for example:

• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear or branched, saturated or unsaturated alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,
• Acylsarcosides having 8 to 24 C atoms in the acyl group,
• Acyltaurides having 8 to 24 carbon atoms in the acyl group,
• Acyl isethionates having 8 to 24 C atoms in the acyl group,
• Sulfosuccinic acid mono- and / or dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic acid monoalkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
• Alpha-olefin sulfonates having 8 to 24 C atoms,
• - Alkyl sulfates and / or alkyl ether sulfate salts of the formula R- (OCH ₂ -CH ₂ ) _n -O-SO ₃ X, in the R preferably a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 30 carbon atoms, x is the number 0 or 1 to 12 and X represents an alkali, alkaline earth, ammonium or alkanolamine ion,
• Sulfonates of unsaturated fatty acids having 8 to 24 C atoms and 1 to 6 double bonds,
• - esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms, and / or
• - Alkyl and / or alkenyl ether of the formula
  
  in the R ^{1 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{2 is} hydrogen, a radical (CH ₂ CH ₂ O) _n R ¹ or X, n is from 0 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or the group -NR ³ R ⁴ R ⁵ R ⁶ stands, with R ³ to R ⁶ independently of one another for a C ₁ to C ₄ hydrocarbon radical.

Preferred anionic surfactants are alkyl sulfates and / or alkyl ether sulfate salts of the formula R- (OCH ₂ -CH ₂ O) _n -O-SO ₃ X, in which R is preferably a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or Alkenyl radical having 8 to 24 carbon atoms, n is 0 or 1 to 12 and X is an alkali, alkaline earth, ammonium or alkanolamine ion.

In a sixth preferred embodiment, the hair treatment compositions according to the invention contain as anionic surfactant c) an alkyl (ether) sulfate of the general formula R- (OCH ₂ -CH ₂ ) _n -OSO ₃ X in which R is a straight-chain or branched, saturated or unsaturated alkyl group with 8 to 24 C atoms, n is the number 0 or 1 to 12, and X is an alkali, alkaline earth, ammonium or alkanolamine ion.

Particularly preferred anionic surfactants c) are straight-chain or branched alkyl ether sulfate salts of the abovementioned formula which contain an alkyl radical R having 8 to 18 and in particular 10 to 16 carbon atoms and 1 to 6 and in particular 2 to 4 ethylene oxide units. Very particular preference is given to the sodium, magnesium and / or triethanolamine salts of linear or branched lauryl, tridecyl and / or myristyl sulfates which have a degree of ethoxylation of from 2 to 4. Especially preferred are the surfactants known under the INCI name Sodium Laureth Sulfate.

The proportion by weight of the anionic surfactant c) in the total weight of the hair treatment compositions according to the invention is preferably 1.00 to 20.00% by weight. More preferred is a weight fraction of from 2.00 to 18.00 wt%, more preferably from 3.00 to 16.00 wt%, most preferably from 4.00 to 14.00 wt%, and especially from 5.00 to 12.50% by weight.

Bevorzugte amphotere und/oder zwitterionische Tenside einer der zuvor genannten Formeln (I) bis (VII) enthalten als Rest R überwiegend einen geradkettigen oder verzweigten, gesättigten, ein- oder mehrfach ungesättigten Alkylrest mit 8 bis 20, mehr bevorzugt von 8 bis 18 und insbesondere mit 8 bis 16 C-Atomen. Besonders bevorzugt sind amphotere und/oder zwitterionische Tenside, bei denen sich der Rest R von Kokosfett ableitet. Ganz besonders bevorzugt sind die unter den INCI-Bezeichnungen Sodium Cocoamphoacetate, Disodium Cocoamphodiacetate, Sodium Lauroamphoacetate, Sodium Lauroamphodiacetate, Sodium Cocoamphopropionate, Disodium Cocoamphodipropionate, Coco Betaine, Lauryl Betaine Cocamidopropylbetain und/oder Lauramidopropylbetain bekannten und im Handel von mehreren Anbietern erhältlichen amphoteren/zwitterionischen Tenside. Insbesondere bevorzugt sind Tenside mit den INCI-Bezeichnungen Cocamidopropylbetain, Lauramidopropylbetain, Cocoampho(di)acetate und/oder Lauroapho(di)acetate.Suitable amphoteric and / or zwitterionic surfactants d) which can be used in the hair treatment compositions according to the invention include, for example, one or more compounds of the following formulas (I) to (VII) in which the radical R is in each case straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 7 to 23 carbon atoms (formulas (I) and (II)) or for a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms ( Formulas (III) to (VII)):

Preferred amphoteric and / or zwitterionic surfactants of the abovementioned formulas (I) to (VII) contain, as radical R, predominantly a straight-chain or branched, saturated, mono- or polyunsaturated alkyl radical having 8 to 20, more preferably 8 to 18 and in particular with 8 to 16 carbon atoms. Particularly preferred are amphoteric and / or zwitterionic surfactants in which the radical R is derived from coconut oil. Very particularly preferred are the amphoteric amines known under the INCI names Sodium Cocoamphoacetate, Disodium Cocoamphodiacetate, Sodium Lauroamphoacetate, Sodium Lauroamphodiacetate, Sodium Cocoamphopropionate, Disodium Cocoamphodipropionate, Coco Betaine, Lauryl Betaine Cocamidopropylbetaine and / or Lauramidopropyl Betain and commercially available from several suppliers. zwitterionic surfactants. Especially preferred are surfactants with the INCI names cocamidopropyl betaine, lauramidopropyl betaine, cocoampho (di) acetate and / or lauroapho (di) acetate.

In a seventh preferred embodiment, the hair cleansing and care compositions according to the invention as zwitterionic and / or amphoteric surfactant d) therefore comprise at least one of the INCI names cocamidopropyl betaine, lauramidopropyl betaine, cocoampho (di) acetate and / or lauroampho (di) acetate Links.

The proportion by weight of the at least one amphoteric and / or zwitterionic surfactant d) in the total weight of the hair treatment compositions according to the invention is preferably 1.00 to 10.00% by weight. More preferred is a weight fraction of from 1.25 to 8.00% by weight, more preferably from 1.50 to 7.50% by weight, most preferably from 1.75 to 6.00% by weight and in particular 2 , 00 to 5.00 wt .-%.

Hair treatment compositions which are preferred according to the invention and which are formulated as an anti-dandruff hair tonic preferably have a pH in the range from 4.0 to 8.5, more preferably from 5.0 to 8.0, particularly preferably from 6.0 to 7.5 and especially from 6.5 to 7.5.

For some embodiments of the hair treatment compositions according to the invention, it may furthermore be advantageous if, in addition to the anti-dandruff combination of the active ingredients a) and b), they contain at least one further antidandruff active ingredient e).

Suitable further antidandruff active ingredients may preferably be selected from the group consisting of Piroctone olamine, climbazole, zinc pyrithione, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts, more preferably from climbazole, zinc pyrithione and / or piroctone olamine. The proportion by weight of the further antidandruff agent e) in the total weight of the hair treatment agent is preferably from 0.01 to 2.50% by weight.

In a further preferred embodiment, the hair treatment compositions according to the invention contain - based on their weight - 0.01 to 2.50 wt .-% of at least one further antidandruff active ingredient e), which is selected from the group consisting of Piroctone olamine, climbazole, pyrithione salts , Ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.

• a) 0,02 bis 2,00 Gew.-%, bevorzugt 0,03 bis 1,75 Gew.-%, mehr bevorzugt 0,04 bis 1,50 Gew.-%, besonders bevorzugt 0,05 bis 1,25 Gew.-% und insbesondere 0,075 bis 1,00 Gew.-% Zinkoxid,
• b) 0,20 bis 20,00 Gew.-%, bevorzugt 0,30 bis 17,50 Gew.-%, mehr bevorzugt 0,40 bis 15,00 Gew.-%, besonders bevorzugt 0,50 bis 12,50 Gew.-% und insbesondere 0,75 bis 10,00 Gew.-% 1,3-Propandiol, und
• c) 0,02 bis 2,00 Gew.-%, bevorzugt 0,03 bis 1,75 Gew.-%, mehr bevorzugt 0,03 bis 1,50 Gew.-%, besonders bevorzugt 0,04 bis 1,25 Gew.-% und insbesondere 0,05 bis 1,00 Gew.-% Climbazol, Zinkpyrithion und/oder Piroctone Olamine.

Particularly preferred hair treatment compositions within this embodiment contain - based on their weight -

• a) 0.02 to 2.00 wt .-%, preferably 0.03 to 1.75 wt .-%, more preferably 0.04 to 1.50 wt .-%, particularly preferably 0.05 to 1.25 Wt .-% and in particular 0.075 to 1.00 wt .-% zinc oxide,
• b) 0.20 to 20.00 wt .-%, preferably 0.30 to 17.50 wt .-%, more preferably 0.40 to 15.00 wt .-%, particularly preferably 0.50 to 12.50 Wt .-% and in particular 0.75 to 10.00 wt .-% of 1,3-propanediol, and
• c) 0.02 to 2.00 wt .-%, preferably 0.03 to 1.75 wt .-%, more preferably 0.03 to 1.50 wt .-%, particularly preferably 0.04 to 1.25 Wt .-% and in particular 0.05 to 1.00 wt .-% climbazole, zinc pyrithione and / or Piroctone Olamine.

In addition to the abovementioned mandatory and optional active ingredients a) to e), it is advantageous if the compositions according to the invention contain further scalp-soothing active ingredients f) and / or scalp-nourishing active ingredients g). In particular, the treatment of scaly, irritated, sensitive and / or injured scalp can be improved if at least one active compound from group f) and / or g) is added to the hair treatment compositions according to the invention.

In a further preferred embodiment, the hair treatment compositions according to the invention therefore contain, based on their weight, additionally 0.01 to 3.00% by weight, preferably 0.02 to 2.50% by weight, particularly preferably 0.03 to 2, 00 wt .-% and in particular 0.05 to 1.50 wt .-% of at least one scalp-soothing agent f) and / or at least one scalp-care agent g).

Suitable active ingredients f) may in the hair treatment compositions according to the invention - based on their weight - preferably in an amount of 0.01 to 2.00 wt .-%, more preferably from 0.02 to 1.50 wt .-%, particularly preferably from 0.03 to 1.00 wt .-% and in particular from 0.05 to 0.75 wt .-% used and preferably selected from allantoin, alpha-bisabolol, alpha-lipoic acid and / or glycyrrethinic acid, preferably from allantoin and / or alpha-bisabolol.

• – kationischen Pflegepolymeren
• – Proteinhydrolysaten,
• – Vitaminen,
• – Fetten, Ölen und/oder Wachsen und/oder
• – Glycerin.

Suitable active ingredients g) can be selected from

• - cationic care polymers
• Protein hydrolysates,
• - vitamins,
• - fats, oils and / or waxes and / or
• - glycerin.

• – quaternisierte Cellulosepolymere, vor allem Polyquaternium-10, wie sie unter den Bezeichnungen Celquat^® und Polymer JR^® im Handel erhältlich sind,
• – hydrophob modifizierte Cellulosederivate, beispielsweise die unter dem Handelsnamen SoftCat^® vertriebenen kationischen Polymere,
• – kationische Alkylpolyglycoside,
• – kationiserter Honig, beispielsweise das Handelsprodukt Honeyquat^® 50,
• – kationische Guar-Derivate, wie insbesondere die unter den Handelsnamen Cosmedia^® Guar N-Hance^® und Jaguar^® vertriebenen Produkte,
• – polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure, vor allem Polyquaternium-6 und Polyquaternium-7. Die unter den Bezeichnungen Merquat^® 100 (Poly(dimethyldiallylammoniumchlorid)) und Merquat^® 550 (Dimethyldiallylammoniumchlorid-Acrylamid-Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere,
• – Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon-Dimethylaminoethylmethacrylat-Copolymere. Solche Verbindungen sind unter den Bezeichnungen Gafquat^® 734 und Gafquat^® 755 im Handel erhältlich,
• – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat^® FC 370, FC 550, FC 905 und HM 552 angeboten werden,
• – quaternierter Polyvinylalkohol,
• – sowie die unter den Bezeichnungen
• – Polyquaternium 2, Polyquaternium 17, Polyquaternium 18, Polyquaternium-24, Polyquaternium 27, Polyquaternium-32, Polyquaternium-37, Polyquaternium 74 und Polyquaternium 89 bekannten Polymere.

Examples of suitable cationic care polymers are:

• - quaternized cellulose polymers, especially polyquaternium-10, such as are available under the names Celquat ^® and Polymer JR ^® commercially,
• - hydrophobically modified cellulose derivatives, for example those sold under the trade name SOFTCAT ^® cationic polymers,
• Cationic alkyl polyglycosides,
• - cationized honey, for example the commercial product Honeyquat ^® 50,
• - cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ^® guar N-Hance ^® and Jaguar ^®,
• - Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid, especially Polyquaternium-6 and Polyquaternium-7. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,
• - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,
• - vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552,
• - quaternized polyvinyl alcohol,
• - as well as the names
• Polyquaternium 2, Polyquaternium 17, Polyquaternium 18, Polyquaternium-24, Polyquaternium 27, Polyquaternium-32, Polyquaternium-37, Polyquaternium 74 and Polyquaternium 89 known polymers.

Particularly preferred cationic polymers are quaternized cellulosic polymers, hydrophobically modified quaternized cellulosic polymers, cationic guar derivatives and / or acrylic acid (derivative) based cationic polymers, which are more preferably selected from the polymers guar hydroxypropyltrimonium chlorides, polyquaternium-4, polyquaternium known under the INCI names -6, Polyquaternium-7, Polyquaternium-10, Polyquaternium-37, Polyquaternium-67 and / or Polyquaternium-72. Particularly preferred are cationic polysaccharide polymers; particularly preferred are the aforementioned quaternized cellulosic polymers. The proportion by weight of the cationic care polymer (s) in the total weight of the hair treatment compositions according to the invention is preferably from 0.01 to 2% by weight, preferably from 0.05 to 1.50% by weight and in particular from 0.10 to 1.00% by weight .-%.

Suitable protein hydrolysates are product mixtures which can be obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins). It can be used protein hydrolysates of plant, animal and / or marine origin.

Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Inolex) and kerasol tm ^® (Croda) sold. Preference is given to protein hydrolysates of plant origin, eg. Soybean, almond, rice, pea, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Inolex) and Crotein ^® (Croda) available. It is also possible to use cationized protein hydrolysates, the protein hydrolyzate on which the animal is based, for example from collagen, milk or keratin, from the plant, for example from wheat, maize, rice, potatoes, soy or almonds, from marine life forms, for example from fish collages or algae, or from biotechnologically derived protein hydrolysates. The protein hydrolysates on which the cationic derivatives are based can be prepared from the corresponding proteins by a chemical, in particular alkaline or acidic Hydrolysis, be obtained by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. Typical examples of the cationic protein hydrolysates and derivatives include the products known under the INCI names: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin , Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Silk, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxyproypltrimonium Hydrolyzed Silk, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Lauridimonium Hydroxypropyl Hydrolyzed Soy Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurodimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimony Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Silk, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Silk, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardime onium Hydroxypropyl Hydrolyzed Wheat Protein, Steartimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Silk, Quaternium-79 Hydrolyzed Soy Protein, Quaternium -79 Hydrolyzed Wheat Protein. The proportion by weight of the protein hydrolyzate (s) in the total weight of the hair treatment agent is preferably from 0.01 to 3% by weight, more preferably from 0.025 to 2% by weight and in particular from 0.05 to 1% by weight.

• • Vitamin A: zur Gruppe der als Vitamin A bezeichneten Substanzen gehören das Retinol (Vitamin A₁) sowie das 3,4-Didehydroretinol (Vitamin A2). Das β-Carotin ist das Provitamin des Retinols. Als Vitamin A-Komponente kommen beispielsweise Vitamin A-Säure und deren Ester, Vitamin A-Aldehyd und Vitamin A-Alkohol sowie dessen Ester wie das Palmitat und das Acetat in Betracht.
• • Vitamin B: zur Vitamin B-Gruppe oder zu dem Vitamin B-Komplex gehören u. a. – Vitamin B₁ (Thiamin) – Vitamin B₂ (Riboflavin) – Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. – Vitamin B₅ (Pantothensäure und Panthenol). Im Rahmen dieser Gruppe wird bevorzugt das Panthenol eingesetzt. Einsetzbare Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols, Pantolacton sowie kationisch derivatisierte Panthenole. Einzelne Vertreter sind beispielsweise das Panthenoltriacetat, der Panthenolmonoethylether und dessen Monoacetat sowie kationische Panthenolderivate. – Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal).
• • Vitamin C (Ascorbinsäure): die Verwendung in Form des Palmitinsäureesters, der Glucoside oder Phosphate kann bevorzugt sein. Die Verwendung in Kombination mit Tocopherolen kann ebenfalls bevorzugt sein.
• • Vitamin E (Tocopherole, insbesondere α-Tocopherol).
• • Vitamin F: unter dem Begriff ”Vitamin F” werden üblicherweise essentielle Fettsäuren, insbesondere Linolsäure, Linolensäure und Arachidonsäure, verstanden.
• • Vitamin H: Als Vitamin H wird die Verbindung (3aS,4S,6aR)-2-Oxohexahydrothienol[3,4-d]-imidazol-4-valeriansäure bezeichnet, für die sich aber zwischenzeitlich der Trivialname Biotin durchgesetzt hat.

Suitable vitamins are preferably the following vitamins, provitamins and vitamin precursors and their derivatives:

• • Vitamin A: the group of substances known as vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A2). The β-carotene is the provitamin of retinol. As vitamin A component, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate into consideration.
• • Vitamin B: the vitamin B group or the vitamin B complex include - Vitamin B ₁ (thiamine) - Vitamin B ₂ (riboflavin) - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. - Vitamin B ₅ (pantothenic acid and panthenol). Within this group the panthenol is preferred. Useful derivatives of panthenol are in particular the esters and ethers of panthenol, pantolactone and cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. - Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).
• Vitamin C (ascorbic acid): use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
• • Vitamin E (tocopherols, especially α-tocopherol).
• • Vitamin F: the term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
• • Vitamin H: Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] -imidazole-4-valeric acid, for which, in the meantime, the trivial name biotin has become established.

Particular preference is given to vitamins, provitamins and vitamin precursors from groups A, B, E and H. Particular preference is given to nicotinamide, biotin, pantolactone and / or panthenol. The proportion by weight of the vitamin (s), vitamin derivative (s), and / or the vitamin precursor (s) in the total weight of the hair treatment agent is preferably from 0.001 to 2% by weight, particularly preferably from 0.005 to 1% by weight and in particular 0, 01 to 0.5 wt .-%.

• (i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind;
• (ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: a) substituierten oder unsubstituierten aminierten Gruppen; b) (per)fluorierten Gruppen; c) Thiolgruppen; d) Carboxylatgruppen; e) hydroxylierten Gruppen; f) alkoxylierten Gruppen; g) Acyloxyalkylgruppen; h) amphoteren Gruppen; i) Bisulfitgruppen; j) Hydroxyacylaminogruppen; k) Carboxygruppen; l) Sulfonsäuregruppen; und m) Sulfat- oder Thiosulfatgruppen;
• (iii) linearen Polysiloxan(A)-Polyoxyalkylen(B)-Blockcopoylmeren vom Typ (A-B)_n mit n > 3;
• (iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde;
• (v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält;
• (vi) oder deren Gemischen.

Suitable fats, oils and / or waxes which can be used in the hair treatment compositions according to the invention are preferably of mineral, natural and synthetic origin. As natural (vegetable) oils usually triglycerides and mixtures of triglycerides are used. Preferred natural oils are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, meadowfoam seed oil, thistle oil, macadamia nut oil, grapeseed oil, Amaranth seed oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter and shea butter. As mineral oils are used in particular mineral oils, paraffin and Isoparaffinöle and synthetic hydrocarbons. An example of a usable hydrocarbon is for example that available as a commercial product 1,3-di- (2-ethylhexyl) -cyclohexane (Cetiol ^® S). As the oil component may further serve a dialkyl ether. Useful dialkyl ethers are in particular di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n -undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether and di tert-butyl ether, di-isopentyl ether, di-3-ethyl decyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methylpentyl n-octyl ether. Particularly preferred is the di-n-octyl ether, which is commercially available under the name Cetiol ^® OE. Suitable synthetic oils are preferably silicone compounds. Silicones have excellent conditioning properties on the hair. In particular, they have a positive effect on the hair grip and the softness of the hair in many cases. It is therefore desirable to use silicones in cosmetic hair treatment compositions. Suitable silicones may be selected from:

• (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
• (ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; l) sulfonic acid groups; and m) sulfate or thiosulfate groups;
• (iii) linear polysiloxane (A) polyoxyalkylene (B) block copolymers of the (AB) _{n type} with n>3;
• (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
• (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;
• (vi) or mixtures thereof.

• – Esteröle. Unter Esterölen sind zu verstehen die Ester von C₆-C₃₀-Fettsäuren mit C₂-C₃₀-Fettalkoholen. Bevorzugt sind die Monoester der Fettsäuren mit Alkoholen mit 2 bis 24 C-Atomen. Beispiele für eingesetzte Fettsäurenanteile in den Estern sind Capronsäure, Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecansäure, Myristinsäure, Palmitinsäure, Palmitoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidinsäure, Petroselinsäure, Linolsäure, Linolensäure, Elaeostearinsäure, Arachinsäure, Gadoleinsäure, Behensäure und Erucasäure sowie deren technische Mischungen. Beispiele für die Fettalkoholanteile in den Esterölen sind Isopropylalkohol, Capronalkohol, Caprylalkohol, 2-Ethylhexylalkohol, Caprinalkohol, Laurylalkohol, Isotridecylalkohol, Myristylalkohol, Cetylalkohol, Palmoleylalkohol, Stearylalkohol, Isostearylalkohol, Oleylalkohol, Elaidylalkohol, Petroselinylalkohol, Linolylalkohol, Linolenylalkohol, Elaeostearylalkohol, Arachylalkohol, Gadoleylalkohol, Behenylalkohol, Erucylalkohol und Brassidylalkohol sowie deren technische Mischungen. Besonders bevorzugt sind Isopropylmyristat (Rilanit^® IPM), Isononansäure-C16-18-alkylester (Cetiol^® SN), 2-Ethylhexylpalmitat (Cegesoft^® 24), Stearinsäure-2-ethylhexylester (Cetiol^® 868) Cetyloleat, Glycerintricaprylat, Kokosfettalkoholcaprinat/-caprylat (Cetiol^® LC), n-Butylstearat, Oleylerucat (Cetiol^® J 600), Isopropylpalmitat (Rilanit^® IPP), Oleyl Oleate (Cetiol^®), Laurinsäurehexylester (Cetiol^® A), Di-n-butyladipat (Cetiol^® B), Myristylmyristat (Cetiol^® MM), Cetearyl Isononanoate (Cetiol^® SN), Ölsäuredecylester (Cetiol^® V).
• – Dicarbonsäureester wie Di-n-butyladipat, Di-(2-ethylhexyl)-adipat, Di-(2-ethylhexyl)-succinat und Di-isotridecylacelaat sowie Diolester wie Ethylenglykol-dioleat, Ethylenglykol-di-isotridecanoat, Propylenglykol-di(2-ethylhexanoat), Propylenglykol-di-isostearat, Propylenglykol-di-pelargonat, Butandiol-di-isostearat, Neopentylglykoldicaprylat,
• – symmetrische, unsymmetrische oder cyclische Ester der Kohlensäure mit Fettalkoholen,
• – Glycerincarbonat oder Dicaprylylcarbonat (Cetiol^® CC),
• – ethoxylierte oder nicht ethoxylierte Mono-, Di- und Trifettsäureester von gesättigten und/oder ungesättigten linearen und/oder verzweigten Fettsäuren mit Glycerin, wie beispielsweise Monomuls^® 90-O18, Monomuls^® 90-L12, Cetiol^® HE oder Cutina^® MD.

Der Gewichtsanteil der Öl-, Wachs- und/oder Fettkomponenten am Gesamtgewicht der erfindungsgemäßen Haarbehandlungsmittel beträgt bevorzugt 0,01 bis 3,00 Gew.-%, besonders bevorzugt 0,025 bis 2,50 Gew.-% und insbesondere 0,05 bis 2,00 Gew.-%.Fatty substances are to be understood fatty acids, fatty alcohols and natural and synthetic waxes, which may be present both in solid form and liquid in aqueous dispersion. As fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids with 6-30 carbon atoms. Preferred are fatty acids with 10-22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and Isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures. Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred. As fatty alcohols it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ -C ₃₀ -, preferably C ₁₀ -C ₂₂ - and very particularly preferably C ₁₂ -C ₂₂ -carbon atoms. For example, decanol, octanol, octenol, dodecenol, decenol, octadienol, dodecadienol, decadienol, oleyl alcohol, erucalcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, capryl alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol, as well as their guerbet alcohols can be used , this list should have exemplary and non-limiting character. However, the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction. Also usable according to the invention are those fatty alcohol cuts which are produced by reduction of naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® , z. B. Stenol ^® 1618 or Lanette ^®, z. B. Lanette ^® O or Lorol ^®, z. B. Lorol® ^® C8, Lorol® ^® C14, C18 Lorol® ^{®, ®} Lorol® C8-18, HD Ocenol ^®, Crodacol ^®, z. B. Crodacol CS ^{®, ®} Novol, Eutanol ^® G, Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb 12 ^{®, ®} Isocarb 16 or Isocarb ^® 24 for sale. Of course, wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used according to the invention. As natural or synthetic waxes may be used solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP. Such waxes are available, for example, from Kahl & Co., Trittau. Other fatty substances are, for example

• - Ester oils. Ester oils are understood as meaning the esters of C ₆ -C ₃₀ -fatty acids with C ₂ -C ₃₀ -fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. Particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868) cetyl oleate, glycerol tricaprylate, Kokosfettalkoholcaprinat / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (Rilanit ^® IPP), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), Cetearyl Isononanoate (Cetiol ^® SN), decyl oleate (Cetiol ^® V).
• Dicarboxylic acid esters such as di-n-butyl adipate, di (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonate, butanediol diisostearate, neopentyl glycol dicaprylate,
• Symmetrical, unsymmetrical or cyclic esters of carbonic acid with fatty alcohols,
• - glycerol carbonate or dicaprylyl ether (Cetiol ^® CC)
• - ethoxylated or non-ethoxylated mono-, di- and trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol such as ^® Monomuls 90-O18, Monomuls 90-L12 ^®, Cetiol ^® HE or Cutina ^® MD.

The proportion by weight of the oil, wax and / or fat components in the total weight of the hair treatment compositions according to the invention is preferably 0.01 to 3.00 wt .-%, particularly preferably 0.025 to 2.50 wt .-% and in particular 0.05 to 2, 00% by weight.

Glycerol can be added separately to the hair treatment compositions of the invention in an amount of up to 10% by weight (based on the total weight of the composition). However, it can also be part of the aforementioned aqueous-alcoholic carrier.

In a further preferred embodiment, the hair treatment compositions according to the invention contain at least one scaling soothing agent f) and / or as at least one conditioning agent g) panthenol, allantoin, alpha-bisabolol, a vegetable oil and / or wax, a cationic polymer and / or glycerol.

Within this embodiment, it is particularly preferred for the hair treatment compositions according to the invention to comprise at least one active ingredient f) or g) selected from the group consisting of panthenol, allantoin, alpha-bisabolol, polyquaternium-10 and / or apricot kernel oil.

To stabilize and / or achieve optimum foam properties and mildness (in the case where the hair treatment compositions according to the invention were formulated as a hair shampoo), the hair treatment compositions according to the invention may contain in a further preferred embodiment, at least one nonionic surfactant and / or a nonionic emulsifier. The proportion by weight of the nonionic surfactant and / or the nonionic emulsifier in the total weight of the hair treatment compositions according to the invention is preferably 0.01 to 3.00 wt .-%, more preferably 0.02 to 2.50 wt .-%, particularly preferably 0.03 to 2.00 wt .-% and in particular 0.05 to 1.50 wt .-%.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C₈-C₃₀-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin,
• – Aminoxide,
• – Sorbitanfettsäureester und Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise Polysorbate,
• – Fettsäurealkanolamide der nachfolgenden allgemeinen Formel,
  
  in der R bevorzugt einen linearen oder verzweigten, gesättigten oder ungesättigten Alkyl- oder Alkenylrest mit 8 bis 24 Kohlenstoffatomen bedeutet und die Reste R' für Wasserstoff oder für die Gruppe -(CH₂)_nOH stehen, in der n die Zahlen 2 oder 3 bedeutet, mit der Maßgabe, dass mindestens einer der Reste R' für den zuvor genannten Rest -(CH₂)_nOH steht,
• – Zuckerfettsäureester und Anlagerungsprodukte von Ethylenoxid an Zuckerfettsäureester,
• – Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine, und/oder
• – Alkyl(oligo)glucoside,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zum Beispiel das im Handel erhältliche Produkt Montanov^® 68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyolen mit 3-6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22 C-Atomen,
• – Sterine. Als Sterine wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 des Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterine) wie auch aus pflanzlichen Fetten (Phytosterine) isoliert werden. Beispiele für Zoosterine sind das Cholesterin und das Lanosterin. Beispiele geeigneter Phytosterine sind Ergosterin, Stigmasterin und Sitosterin. Auch aus Pilzen und Hefen werden Sterine, die sogenannten Mykosterine, isoliert.
• – Phospholipide. Hierunter werden vor allem die Glucose-Phospolipide, die z. B. als Lecithine bzw. Phospahtidylcholine aus z. B. Eidotter oder Pflanzensamen (z. B. Sojabohnen) gewonnen werden.

Geeignete Alkyl(oligo)glycoside können ausgewählt sein aus Verbindungen der allgemeinen Formel der RO-[G]_x, in denen sich [G] bevorzugt von Aldosen und/oder Ketosen mit 5-6 Kohlenstoffatomen, vorzugsweise von Glucose ableitet. Die Indexzahl x steht für den Oligomerisierungsgrad (DP), d. h. für die Verteilung der Mono- und Oligoglycoside. Die Indexzahl x weist vorzugsweise einen Wert im Bereich von 1 bis 10, besonders bevorzugt im Bereich von 1 bis 3 auf, wobei es sich dabei um keine ganze Zahl, sondern um eine gebrochene Zahl handeln kann, die analytisch ermittelt werden kann. Besonders bevorzugte Alkyl(oligo)glycoside weisen einen Oligomerisierungsgrad zwischen 1,2 und 1,5 auf. Der Rest R steht bevorzugt für mindestens einen Alkyl- und/oder Alkenylrest mit 4 bis 24 C-Atomen. Insbesondere bevorzugte Alkyl(oligo)glycoside sind die unter den INCI-Bezeichnungen Caprylyl/Capryl Glucoside, Decyl Glucoside, Lauryl Glucoside und Coco Glucoside bekannten Verbindungen. Geeignete Aminoxide können ausgewählt sein aus mindestens einer Verbindung der allgemeinen Formeln (I) oder (II)

in denen R jeweils für einen geradkettigen oder verzweigten, gesättigten oder ein- oder mehrfach ungesättigten Alkyl- oder Alkenylrest mit 6 bis 24 Kohlenstoffatomen, bevorzugt mit 8 bis 18 Kohlenstoffatomen steht. Insbesondere bevorzugt sind die unter den INCI-Bezeichnungen Cocamine Oxide, Lauramine Oxide und/oder Cocamidopropylaminoxid bekannten und im Handel von verschiedenen Anbietern erhältlichen Tenside der zuvor genannten Formel (I) oder (II). Unter geeigneten C₈-C₃₀-Fettsäuremono- und -diestern von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin werden bevorzugt die unter den INCI-Bezeichnungen PEG(1-10) Glyceryl Cocoate, insbesondere PEG-7 Glyceryl Cocoate verstanden.The nonionic surfactants / emulsifiers suitable according to the invention are preferred

• Addition products of from 4 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide onto linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids containing from 12 to 22 carbon atoms and to alkylphenols having from 8 to 15 carbon atoms in the alkyl group,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C ₈ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 mol of ethylene oxide with glycerol,
• - amine oxides,
• Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as polysorbates,
• Fatty acid alkanolamides of the following general formula
  
  in which R is preferably a linear or branched, saturated or unsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and the radicals R 'are hydrogen or the group - (CH ₂ ) _n OH, in which n is the numbers 2 or 3 with the proviso that at least one of the radicals R 'is the abovementioned radical - (CH ₂ ) _n OH,
• Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,
• Addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines, and / or
• - alkyl (oligo) glucosides,
• Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68, -
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 C atoms,
• - sterols. Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
• - Phospholipids. These include, above all, the glucose phospholipids, which are z. B. as lecithins or Phospahtidylcholine from z. Egg yolks or plant seeds (eg soybeans).

Suitable alkyl (oligo) glycosides may be selected from compounds of the general formula RO- [G] _x , in which [G] is preferably derived from aldoses and / or ketoses having 5-6 carbon atoms, preferably glucose. The index number x stands for the degree of oligomerization (DP), ie for the distribution of the mono- and oligoglycosides. The index number x preferably has a value in the range of 1 to 10, especially preferably in the range of 1 to 3, which may not be an integer, but a fractional number, which can be determined analytically. Particularly preferred alkyl (oligo) glycosides have a degree of oligomerization between 1.2 and 1.5. The radical R is preferably at least one alkyl and / or alkenyl radical having 4 to 24 carbon atoms. Particularly preferred alkyl (oligo) glycosides are the compounds known under the INCI names Caprylyl / Capryl Glucoside, Decyl Glucoside, Lauryl Glucoside and Coco Glucoside. Suitable amine oxides may be selected from at least one compound of the general formulas (I) or (II)

in which R in each case represents a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 6 to 24 carbon atoms, preferably having 8 to 18 carbon atoms. Particularly preferred are the known under the INCI names Cocamine oxides, lauramine oxides and / or Cocamidopropylaminoxid and commercially available from various suppliers surfactants of the aforementioned formula (I) or (II). Suitable C ₈ -C ₃₀ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto glycerol are preferably understood to mean the glyceryl cocoate, in particular PEG-7 glyceryl cocoate, under the INCI names PEG (1-10).

It may also be advantageous to combine the ethoxylated fatty acid esters with other ethoxylated fatty acid esters. Such product mixtures are commercially available - for example, under the name "Antil 200 ^® " (INCI name: PEG-200 Hydrogenated Glyceryl Palmate, PEG-7 Glyceryl Cocoate) from Evonik. Particularly preferred nonionic surfactants which may be present in the compositions according to the invention are fatty acid alkanolamides, in particular the compounds known under the INCI names Cocamide MEA and / or Cocamide MIPA; Alkyl (oligo) glucosides, in particular the compounds known under the INCI names Caprylyl / Capryl Glucoside, Decyl Glucoside, Lauryl Glucoside and / or Coco Glucoside; C ₈ -C ₃₀ fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol, in particular the compound known by the INCI name PEG-7 glyceryl cocoate; and / or addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear fatty alcohols having 8 to 22 carbon atoms.

For certain embodiments, it may also be advantageous if the hair treatment compositions according to the invention contain hydrogenated castor oil. It has been found that a content of hydrogenated castor oil can assist the stabilization of the - preferably water-insoluble - inorganic zinc salt a) in the hair treatment compositions according to the invention. In a further preferred embodiment, the hair treatment compositions according to the invention therefore contain - based on their weight - preferably 0.01 to 2.00 wt .-%, more preferably 0.02 to 1.50 wt .-%, particularly preferably 0.03 to 1 , 00 wt .-% and in particular 0.05 to 0.50 wt .-% hydrogenated castor oil g) (INCI name: Hydrogenated Castor Oil).

• – Pflanzenextrakte,
• – Feuchthaltemittel,
• – Parfums,
• – UV-Filter,
• – Verdickungsmittel wie Gelatine oder Pflanzengumme, beispielsweise Agar-Agar, Guar-Gum, Alginate, Xanthan-Gum, Gummi arabicum, Karaya-Gummi, Johannisbrotkernmehl, Leinsamengummen, Dextrane, Cellulose-Derivate, z. B. Methylcellulose, Hydroxyalkylcellulose und Carboxymethylcellulose, Stärke-Fraktionen und Derivate wie Amylose, Amylopektin und Dextrine, Tone und Schichtsilikate wie z. B. Bentonit oder vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol, die Ca-, Mg- oder Zn-Seifen,
• – Verdickungsmittel wie Acryl- und Methacryl(co)polymere, beispielsweise die vernetzten Homopolymere der Acrylsäure (INCI-Bezeichnung: Carbomer), die auch als Carboxyvinylpolymere bezeichnet werden. Solche Polyacrylsäuren sind unter anderem von der Fa. 3V Sigma unter dem Handelsnamen Polygel^®, z. B. Polygel DA und von der Fa. B. F. Goodrich unter dem Handelsnamen Carbopol^® erhältlich, z. B. Carbopol 940 (Molekulargewicht ca. 4.000.000), Carbopol 941 (Molekulargewicht ca. 1. 250.000) oder Carbopol 934 (Molekulargewicht ca. 3.000.000). Weiterhin sind beispielsweise folgende AcrylsäureCopolymere geeignet: a. Copolymere von zwei oder mehr Monomeren aus der Gruppe der Acrylsäure, Methacrylsäure und ihrer einfachen, vorzugsweise mit C1-C4-Alkanolen gebildeten, Ester (INCI-Bezeichnung: Acrylates Copolymer), zu denen etwa die Copolymere von Methacrylsäure, Butylacrylat und Methylmethacrylat oder von Butylacrylat und Methylmethacrylat gehören, und die beispielsweise von der Fa. Rohm & Haas unter den Handelsnamen Aculyn^® und Acusol^® sowie von der Firma Degussa (Goldschmidt) unter dem Handelsnamen Tego^® Polymer erhältlich sind, z. B. Aculyn 22, Aculyn 28, Aculyn 33 (vernetzt), Acusol 810, Acusol 820, Acusol 823 und Acusol 830; b. vernetzte hochmolekulare Acrylsäure-Copolymere, zu denen etwa die mit einem Allylether der Saccharose oder des Pentaerythrits vernetzten Copolymere von C10-C30-Alkylacrylaten mit einem oder mehreren Monomeren aus der Gruppe der Acrylsäure, Methacrylsäure und ihrer einfachen, vorzugsweise mit C1-C4-Alkanolen gebildeten, Ester (INCI-Bezeichnung: Acrylates-(C10-C30)-Alkyl Acrylate Crosspolymer) gehören, und die beispielsweise von der Fa. B. F. Goodrich unter dem Handelsnamen Carbopol^® erhältlich sind, z. B. Carbopol ETD 2020 und Carbopol 1382 (INCI Acrylates-(C10-C30)-Alkyl Acrylate Crosspolymer) sowie Carbopol Aqua 30,
• – Strukturanten wie Maleinsäure und Milchsäure,
• – Farbstoffe zum Anfärben des Mittels,
• – Substanzen zur Einstellung des pH-Wertes, beispielsweise α- und β-Hydroxycarbonsäuren wie Citronensäure, Milchsäure, Äpfelsäure, Glycolsäure, und/oder Basen wie Alkanolamine und/oder Natriumhydroxid,
• – Komplexbildner wie EDTA, NTA, β-Alanindiessigsäure und Phosphonsäuren,
• – Ceramide. Unter Ceramiden werden N-Acylsphingosin (Fettsäureamide des Sphingosins) oder synthetische Analogen solcher Lipide (sogenannte Pseudo-Ceramide) verstanden,
• – Treibmittel wie Propan-Butan-Gemische, N₂O, Dimethylether, CO₂ und Luft,
• – Antioxidantien,
• – Konservierungsmittel, wie beispielsweise Natriumbenzoat oder Salicylsäure,
• – Zusätzliche Viskositätsregler wie Salze (NaCl).

Further active ingredients, auxiliaries and additives which may preferably be present in the hair treatment compositions according to the invention are, for example:

• - plant extracts,
• - humectants,
• - perfumes,
• - UV filters,
• Thickeners such as gelatin or vegetable gums, for example agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. As methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays and phyllosilicates such. As bentonite or fully synthetic hydrocolloids such. As polyvinyl alcohol, the Ca, Mg or Zn soaps,
• Thickeners such as acrylic and methacrylic (co) polymers, for example the crosslinked homopolymers of acrylic acid (INCI name: carbomer), which are also referred to as carboxyvinyl polymers. Such polyacrylic acids are inter alia from the company. 3V Sigma under the trade name Polygel ^® , z. B. Polygel DA and by the company. BF Goodrich under the trade name Carbopol ^® available, z. Carbopol 940 (molecular weight about 4,000,000), Carbopol 941 (molecular weight about 1 250,000) or Carbopol 934 (molecular weight about 3,000,000). Furthermore, for example, the following acrylic acid copolymers are suitable: a. Copolymers of two or more monomers from the group of acrylic acid, methacrylic acid and their simple, preferably with C1-C4-alkanols formed ester (INCI name: Acrylates Copolymer), such as the copolymers of methacrylic acid, butyl acrylate and methyl methacrylate or butyl acrylate and methyl methacrylate include, and are obtainable for example from Messrs. Rohm & Haas under the trade names Aculyn ^® and Acusol ^®, and from Degussa (Goldschmidt) under the trade name Tego ^® polymer, eg. Aculyn 22, Aculyn 28, Aculyn 33 (cross-linked), Acusol 810, Acusol 820, Acusol 823 and Acusol 830; b. crosslinked high molecular weight acrylic acid copolymers, such as those crosslinked with an allyl ether of sucrose or pentaerythritol copolymers of C10-C30 alkyl acrylates with one or more monomers selected from the group consisting of acrylic acid, methacrylic acid and their simple, preferably with C1-C4 alkanols , esters (INCI name: Acrylates- (C10-C30) alkyl acrylates crosspolymer), and which are obtainable for example by the company BF Goodrich under the trade name Carbopol ^®, z.. Carbopol ETD 2020 and Carbopol 1382 (INCI Acrylates (C10-C30) alkyl acrylate crosspolymer) and Carbopol Aqua 30,
• - structurants such as maleic acid and lactic acid,
• Dyes for staining the agent,
• Substances for adjusting the pH, for example α- and β-hydroxycarboxylic acids such as citric acid, lactic acid, malic acid, glycolic acid, and / or bases such as alkanolamines and / or sodium hydroxide,
• Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
• - Ceramides. Ceramides are understood as meaning N-acylsphingosine (fatty acid amides of sphingosine) or synthetic analogs of such lipids (so-called pseudo-ceramides),
• Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,
• - antioxidants,
• Preservatives, such as sodium benzoate or salicylic acid,
• - Additional viscosity regulators such as salts (NaCl).

A second object of the invention is the cosmetic use of at least one C ₂ -C ₄ diol, preferably of 1,3-propylene glycol and / or 1,2-propylene glycol, for increasing the anti-dandruff efficacy of hair treatment compositions containing at least one inorganic zinc salt, preferably zinc oxide , as antidandruff active ingredient.

• I. Aufbringen eines Haarbehandlungsmittels, enthaltend – bezogen auf sein Gewicht – a. 0,01 bis 2,50 Gew.-% mindestens eines anorganischen Zinksalzes, vorzugsweise Zinkoxid, und b. 0,10 bis 25,00 Gew.-% mindestens eines C₂-C₄-Diols auf die (vorzugsweise nassen) Haare,
• II. Einwirken lassen des Haarbehandlungsmittels für 5 Sekunden bis 24 Stunden,
• III. ggfs. Ausspülen des Haarbehandlungsmittels mit Wasser,
• IV. Trocknen der Haare.

A third aspect of the invention is a cosmetic process for the removal, reduction, alleviation and / or prevention of dandruff, characterized by the following process steps:

• I. application of a hair treatment composition containing - based on its weight - a. 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, preferably zinc oxide, and b. 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol on the (preferably wet) hair,
• II. Allowing the hair treatment agent to act for 5 seconds to 24 hours,
• III. if necessary rinsing the hair treatment agent with water,
• IV. Drying of the hair.

For preferred embodiments of the use according to the invention and of the method according to the invention, the statements made on the hair treatment compositions according to the invention apply mutatis mutandis.

• 1. Haarbehandlungsmittel, enthaltend – bezogen auf sein Gewicht – a) 0,01 bis 2,50 Gew.-% mindestens eines anorganischen Zinksalzes, und b) 0,10 bis 25,00 Gew.-% mindestens eines C₂-C₄-Diols.
• 2. Haarbehandlungsmittel nach Punkt 1, dadurch gekennzeichnet, dass mindestens ein wasserunlösliches anorganisches Zinksalz a) eingesetzt wird.
• 3. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass das anorganische Zinksalz a) ausgewählt ist aus Zinkoxid und/oder Zinkcarbonat.
• 4. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – 0,02 bis 2,00 Gew.-%, bevorzugt 0,03 bis 1,75 Gew.-%, mehr bevorzugt 0,04 bis 1,50 Gew.-%, besonders bevorzugt 0,05 bis 1,25 Gew.-% und insbesondere 0,075 bis 1,00 Gew.-% Zinkoxid enthält.
• 5. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – 0,20 bis 20,00 Gew.-%, bevorzugt 0,30 bis 17,50 Gew.-%, mehr bevorzugt 0,40 bis 15,00 Gew.-%, besonders bevorzugt 0,50 bis 12,50 Gew.-% und insbesondere 0,75 bis 10,00 Gew.-% 1,2-Propylenglycol, 1,3-Propylenglycol, 1,2-Butylenglycol, 1,3-Butylenglycol und/oder 1,4-Butylenglycol enthält.
• 6. Haarbehandlungsmittel nach Punkt 5, dadurch gekennzeichnet, dass es 1,2-Propylenglycol und/oder 1,3-Propylenglycol, vorzugsweise 1,3-Propylenglycol, enthält.
• 7. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – 0,10 bis 25,00 Gew.-% mindestens eines Tensids, vorzugsweise mindestens eines anionischen Tensids c) und mindestens eines amphoteren/zwitterionischen Tensids d) enthält.
• 8. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass das mindestens eine anionische Tensid c) ausgewählt ist aus Alkyl(ether)sulfaten der allgemeinen Formel R-(OCH₂-CH₂)_n-OSO₃X, in der R eine geradkettige oder verzweigte, gesättigte oder ungesättigte Alkylgruppe mit 8 bis 24 C-Atomen, n die Zahl 0 oder 1 bis 12, und X ein Alkali-, Erdalkali-, Ammonium- oder Alkanolaminion bedeutet.
• 9. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass das mindestens eine zwitterionische und/oder amphotere Tensid d) ausgewählt ist aus mindestens einer der unter den INCI-Bezeichnungen Cocamidopropylbetain, Lauramidopropylbetain, Cocoampho(di)acetate und/oder Lauroampho(di)acetate bekannten Verbindungen.
• 10. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – zusätzlich 0,01 bis 2,50 Gew.-% mindestens eines weiteren Antischuppenwirkstoffs e) enthält, der ausgewählt ist aus der Gruppe, die gebildet wird aus Piroctone Olamine, Climbazol, Pyrithionsalzen, Ketoconazole, Salicylsäure, Schwefel, Selensulfid, Teerpräparaten, Undecensäurederivaten, Klettenwurzelextrakten, Pappelextrakten, Brennesselextrakten, Walnussschalenextrakten, Birkenextrakten, Weidenrindenextrakten, Rosmarinextrakten und/oder Arnikaextrakten.
• 11. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – a) 0,02 bis 2,00 Gew.-%, bevorzugt 0,03 bis 1,75 Gew.-%, mehr bevorzugt 0,04 bis 1,50 Gew.-%, besonders bevorzugt 0,05 bis 1,25 Gew.-% und insbesondere 0,075 bis 1,00 Gew.-% Zinkoxid, b) 0,20 bis 20,00 Gew.-%, bevorzugt 0,30 bis 17,50 Gew.-%, mehr bevorzugt 0,40 bis 15,00 Gew.-%, besonders bevorzugt 0,50 bis 12,50 Gew.-% und insbesondere 0,75 bis 10,00 Gew.-% 1,3-Propandiol, und c) 0,02 bis 2,00 Gew.-%, bevorzugt 0,03 bis 1,75 Gew.-%, mehr bevorzugt 0,03 bis 1,50 Gew.-%, besonders bevorzugt 0,04 bis 1,25 Gew.-% und insbesondere 0,05 bis 1,00 Gew.-% Climbazol, Zinkpyrithion und/oder Piroctone Olamine enthält.
• 12. Haarbehandlungsmittel nach einem der vorhergehenden Punkte, dadurch gekennzeichnet, dass es – bezogen auf sein Gewicht – zusätzlich 0,01 bis 3,00 Gew.-%, bevorzugt 0,02 bis 2,50 Gew.-%, besonders bevorzugt 0,03 bis 2,00 Gew.-% und insbesondere 0,05 bis 1,50 Gew.-% mindestens eines die Kopfhaut beruhigenden Wirkstoffs f) und/oder mindestens eines die Kopfhaut pflegenden Wirkstoffs g) enthält.
• 13. Haarbehandlungsmittel nach Punkt 12, dadurch gekennzeichnet, dass der mindestens eine die Kopfhaut beruhigende Wirkstoff f) und/oder der mindestens eine die Kopfhaut pflegende Wirkstoff g) ausgewählt ist aus Panthenol, Allantoin, alpha-Bisabolol, pflanzlichen Ölen und/oder Wachsen, kationischen Polymeren und/oder Glycerin.
• 14. Kosmetische Verwendung mindestens eines C₂-C₄-Diols, vorzugsweise von 1,3-Propylenglycol und/oder 1,2-Propylenglycol, zur Steigerung der Antischuppenwirksamkeit von Haarbehandlungsmitteln, die mindestens ein anorganisches Zinksalz, vorzugsweise Zinkoxid, als Antischuppenwirkstoff enthalten.
• 15. Kosmetisches Verfahren zur Beseitigung, Verminderung, Linderung und/oder Vorbeugung von Kopfschuppen, gekennzeichnet durch die folgenden Verfahrensschritte: I. Aufbringen eines Haarbehandlungsmittels, enthaltend – bezogen auf sein Gewicht – a. 0,01 bis 2,50 Gew.-% mindestens eines anorganischen Zinksalzes, vorzugsweise Zinkoxid, und b. 0,10 bis 25,00 Gew.-% mindestens eines C₂-C₄-Diols auf die (vorzugsweise nassen) Haare, II. Einwirken lassen des Haarbehandlungsmittels für 5 Sekunden bis 24 Stunden, III. ggfs. Ausspülen des Haarbehandlungsmittels mit Wasser, IV. Trocknen der Haare.

The articles of the invention as well as some of their particularly preferred embodiments are characterized as follows:

• 1. hair treatment composition containing - based on its weight - a) 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, and b) 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol.
• 2. hair treatment composition according to item 1, characterized in that at least one water-insoluble inorganic zinc salt a) is used.
• 3. Hair treatment composition according to one of the preceding points, characterized in that the inorganic zinc salt a) is selected from zinc oxide and / or zinc carbonate.
• 4. hair treatment composition according to one of the preceding points, characterized in that it - based on its weight - 0.02 to 2.00 wt .-%, preferably 0.03 to 1.75 wt .-%, more preferably 0.04 to 1.50 wt .-%, particularly preferably 0.05 to 1.25 wt .-% and in particular 0.075 to 1.00 wt .-% zinc oxide.
• 5. Hair treatment composition according to one of the preceding points, characterized in that it - based on its weight - 0.20 to 20.00 wt .-%, preferably 0.30 to 17.50 wt .-%, more preferably 0.40 to 15.00 wt.%, particularly preferably 0.50 to 12.50 wt.% and in particular 0.75 to 10.00 wt. % 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol and / or 1,4-butylene glycol.
• 6. Hair treatment composition according to item 5, characterized in that it contains 1,2-propylene glycol and / or 1,3-propylene glycol, preferably 1,3-propylene glycol.
• 7. hair treatment composition according to one of the preceding points, characterized in that it - based on its weight - 0.10 to 25.00 wt .-% of at least one surfactant, preferably at least one anionic surfactant c) and at least one amphoteric / zwitterionic surfactant d ) contains.
• 8. hair treatment composition according to one of the preceding points, characterized in that the at least one anionic surfactant c) is selected from alkyl (ether) sulfates of the general formula R- (OCH ₂ -CH ₂ ) _n -OSO ₃ X, in the R a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 24 carbon atoms, n is the number 0 or 1 to 12, and X is an alkali, alkaline earth, ammonium or alkanolamine ion.
• 9. Hair treatment composition according to one of the preceding points, characterized in that the at least one zwitterionic and / or amphoteric surfactant d) is selected from at least one of the INCI names Cocamidopropylbetain, Lauramidopropylbetain, Cocoampho (di) acetate and / or Lauroampho (di ) Acetates known compounds.
• 10. Hair treatment composition according to one of the preceding points, characterized in that it contains - based on its weight - additionally 0.01 to 2.50 wt .-% of at least one further antidandruff active ingredient e), which is selected from the group which is formed from Piroctone olamine, climbazole, pyrithione salts, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.
• 11. Hair treatment composition according to one of the preceding points, characterized in that it - based on its weight - a) 0.02 to 2.00 wt .-%, preferably 0.03 to 1.75 wt .-%, more preferably 0 , 04 to 1.50 wt .-%, particularly preferably 0.05 to 1.25 wt .-% and in particular 0.075 to 1.00 wt .-% zinc oxide, b) 0.20 to 20.00 wt .-% , preferably 0.30 to 17.50% by weight, more preferably 0.40 to 15.00% by weight, particularly preferably 0.50 to 12.50% by weight and in particular 0.75 to 10.00 Wt% 1,3-propanediol, and c) 0.02 to 2.00 wt%, preferably 0.03 to 1.75 wt%, more preferably 0.03 to 1.50 wt%. %, more preferably 0.04 to 1.25 wt .-% and in particular 0.05 to 1.00 wt .-% climbazole, zinc pyrithione and / or Piroctone olamine contains.
• 12. hair treatment composition according to one of the preceding points, characterized in that it - based on its weight - additionally 0.01 to 3.00 wt .-%, preferably 0.02 to 2.50 wt .-%, particularly preferably 0, 03 to 2.00 wt .-% and in particular 0.05 to 1.50 wt .-% of at least one scalp-soothing agent f) and / or at least one scalp-maintaining active ingredient g).
• 13. Hair treatment composition according to item 12, characterized in that the at least one scalp soothing agent f) and / or the at least one scalp-care agent g) is selected from panthenol, allantoin, alpha-bisabolol, vegetable oils and / or waxes, cationic polymers and / or glycerin.
• 14. Cosmetic use of at least one C ₂ -C ₄ diol, preferably of 1,3-propylene glycol and / or 1,2-propylene glycol, for increasing the anti-dandruff efficacy of hair treatment compositions containing at least one inorganic zinc salt, preferably zinc oxide, as anti-dandruff active.
• 15. Cosmetic process for the elimination, reduction, alleviation and / or prevention of dandruff, characterized by the following process steps: I. Application of a hair treatment composition containing - based on its weight - a. 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, preferably zinc oxide, and b. 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol on the (preferably wet) hair, II. Allow to act on the hair treatment agent for 5 seconds to 24 hours, III. if necessary, rinse the hair treatment agent with water, IV. drying the hair.

Examples:

The following hair treatment compositions 1 (hair tonic) and 2 to 5 (hair shampoos) according to the invention were prepared. The quantities in the tables refer to [% by weight]): 1 2 3 4 5 Carbomer 0.40 NaOH 0.04 ethanol 15.00 allantoin 0.10 panthenol 0.20 Coco Glucoside 0.30 Perfume 0.20 Zinc oxide* 0.50 1,3-propylene glycol 10.00 water ad 100 pH (adjusted with NaOH and HCl) 7.0 ± 0.5 Sodium Laureth Sulfate (AS) 10.00 10.00 10.00 10.00 Cocoamidopropyl Betaine (AS) 3.20 3.20 3.20 3.20 PEG-7 glyceryl cocoate 0.40 0.40 0.40 0.40 PEG-40 Hydrogenated Castor Oil 0.30 0.30 0.30 0.30 Guar hydroxypropyltrimonium chlorides 0.20 0.20 Polyquaternium-10 0.50 0.50 1,3-propylene glycol 5.00 5.00 1,2-propylene glycol 5.00 5.00 zinc oxide 2.00 2.00 1.00 zinc carbonate 1.00 1.75 sodium benzoate 0.75 0.75 0.75 0.75 citric acid 0.10 0.10 0.10 0.10 Hydrogenated Castor Oil 0.30 0.30 0.30 0.30 NaCl 1.10 1.10 1.10 1.10 Perfume 0.60 0.60 0.60 0.60 water ad 100 ad 100 ad 100 ad 100 PH value 5.5 ± 0.2 5.5 ± 0.2 5.5 ± 0.2 5.5 ± 0.2 Viscosity (Brookfield viscometer, 20 ° C, 20 rpm, spindle 5) [mPas] 8,000 - 12,000 8,000 - 12,000 8,000 - 12,000 8,000 - 12,000

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• GB 2205743 A [0002]
• EP 348015 A1 [0002]
• EP 1238645 A1 [0002]

Claims (10)

Hair treatment composition containing - based on its weight - a) 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, and b) 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol , Hair treatment composition according to claim 1, characterized in that at least one water-insoluble inorganic zinc salt a) is used. Hair treatment composition according to one of the preceding claims, characterized in that the inorganic zinc salt a) is selected from zinc oxide and / or zinc carbonate. Hair treatment composition according to one of the preceding claims, characterized in that it - based on its weight - 0.02 to 2.00 wt .-%, preferably 0.03 to 1.75 wt .-%, more preferably 0.04 to 1 , 50 wt .-%, particularly preferably 0.05 to 1.25 wt .-% and in particular 0.075 to 1.00 wt .-% zinc oxide. Hair treatment composition according to one of the preceding claims, characterized in that it - based on its weight - 0.20 to 20.00 wt .-%, preferably 0.30 to 17.50 wt .-%, more preferably 0.40 to 15 , 00 wt .-%, particularly preferably 0.50 to 12.50 wt .-% and in particular 0.75 to 10.00 wt .-% 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol , 1,3-butylene glycol and / or 1,4-butylene glycol. Hair treatment composition according to claim 5, characterized in that it contains 1,2-propylene glycol and / or 1,3-propylene glycol, preferably 1,3-propylene glycol. Hair treatment composition according to one of the preceding claims, characterized in that it contains - based on its weight - 0.10 to 25.00 wt .-% of at least one surfactant, preferably at least one anionic surfactant c) and at least one amphoteric / zwitterionic surfactant d) , Hair treatment composition according to one of the preceding claims, characterized in that it contains - based on its weight - additionally 0.01 to 2.50 wt .-% of at least one further antidandruff active ingredient e), which is selected from the group which is formed from Piroctone Olamine, climbazole, pyrithione salts, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts. Cosmetic use of at least one C ₂ -C ₄ diol, preferably of 1,3-propylene glycol and / or 1,2-propylene glycol, for increasing the anti-dandruff efficacy of hair treatment compositions containing at least one inorganic zinc salt, preferably zinc oxide, as anti-dandruff active. Cosmetic process for the elimination, reduction, alleviation and / or prevention of dandruff, characterized by the following process steps: I. Application of a hair treatment composition containing - by weight - a. 0.01 to 2.50 wt .-% of at least one inorganic zinc salt, preferably zinc oxide, and b. 0.10 to 25.00 wt .-% of at least one C ₂ -C ₄ diol on the (preferably wet) hair, II. Allow to act on the hair treatment agent for 5 seconds to 24 hours, III. if necessary, rinse the hair treatment agent with water, IV. drying the hair.